Pharmaceutical manufacturing is the industrial-scale process of producing medications through chemical synthesis, biotechnology, or extraction, ensuring both quality and regulatory compliance.

Analysts warn of price risks even as generics, U.S. facilities, and European caps could blunt the impact.

President Donald Trump has said drug companies who do not comply with the order to lower prices will face penalties.

Only 1 in 10 of the prescriptions filled in the U.S. are for brand-name drugs; the vast majority are for generics, which are ...

There is a complex pharmaceutical manufacturing dynamic wherein efforts to repatriate pharmaceutical production to the United States with a goal ...

Trump issued an executive order (EO) to protect the security of the U.S. drug market by ordering a list of essential ...

As technology advances worldwide, and as more people including Liberians spend longer hours in front of screens, the demand for vision correction is expected to grow. Health experts warn that the rise ...

Crown glass occupies a specialized niche within the broader optical and specialty glass market, accounting for an estimated ...

The biopharmaceutical industry is responding to Trump’s call to put America first by announcing three major actions to lower ...

Any scrapping or even undercutting of the PBS, on which the Australian government spent nearly $18 billion last year to ...

America’s high drug prices have long exercised politicians on both sides of the aisle. According to a study by the RAND ...